Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas

PHASE2RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2031

Conditions
Neuroendocrine CarcinomaDigestive Cancer
Interventions
DRUG

Neoadjuvant treatment

4 cycles of platinum-based chemotherapy (carboplatin or cisplatin) plus etoposide followed by surgery or chemoradiotherapy

DRUG

Adjuvant treatment

Surgery (before study entry) followed by 4 cycles of platinum-based chemotherapy (carboplatin or cisplatin) plus etoposide

Trial Locations (14)

75012

RECRUITING

Saint Antoine Hospital, Paris

Unknown

RECRUITING

CHU Amiens - Hôpital Sud, Amiens

RECRUITING

CHU Jean Minjoz, Besançon

RECRUITING

Hôpital Beaujon, Clichy

RECRUITING

CHU Dijon, Dijon

NOT_YET_RECRUITING

Hôpital Edouard Herriot, Lyon

NOT_YET_RECRUITING

Institut Paoli-Calmettes, Marseille

NOT_YET_RECRUITING

Groupe Hospitalier Diaconesses Croix Saint Simon, Paris

NOT_YET_RECRUITING

Hôpital Cochin, Paris

RECRUITING

Hôpital Saint Antoine, Paris

RECRUITING

Hôpital Haut Lévêque CHU Bordeaux, Pessac

RECRUITING

CHU Poitiers, Poitiers

RECRUITING

CHU Toulouse, Toulouse

NOT_YET_RECRUITING

Institut Gustave Roussy, Villejuif

All Listed Sponsors
collaborator

Fondation ARCAD

OTHER

lead

GERCOR - Multidisciplinary Oncology Cooperative Group

OTHER